drugset / Trial / NCT01558128

Combined Amiodarone and Electrical Cardioversion for Postoperative Atrial Fibrillation After Cardiac Surgery

NCT01558128 ↗

NaSingle-groupOpen-labelTreatment

Summary

To determine the efficacy of cardioversion and amiodarone for cardiac patients who develop postoperative atrial fibrillation

Timeline

Start
2012-03
Primary completion
2013-03
Completion
2013-03

Outcome

Outcome not reported

Stopped (Enrollment): “Insufficient Recruitment”

Drugs

EvaluationDrugModalityDoseRoute
Subject Amiodarone Small molecule 0.5 mg Intravenous

Indications